GABA Supplements Market to Hit US$76 Mn by 2033, Reports Persistence Market Research

The GABA Supplements Market has shown promising growth in recent years, with global sales valued at approximately USD 42 million in 2022. According to Persistence Market Research, the market is set to experience a compound annual growth rate (CAGR) of 5.7% from 2023 to 2033, reaching a projected valuation of USD 76 million by the end of the forecast period. Capsules remain the leading product form, anticipated to grow at a CAGR of over 5.3% from 2023 to 2033, driving the market's expansion significantly.

Get a Sample report at - https://www.persistencemarketresearch.com/samples/33376

Historical Market Performance and Future Outlook

From 2018 to 2022, the GABA Supplements Market exhibited a steady growth trajectory, with a CAGR of approximately 3.5%. This period highlighted a rising awareness of the benefits of GABA supplements, which promote relaxation, improved sleep, and mental well-being. Moving forward, the market's potential remains robust, supported by an absolute dollar opportunity of USD 32.5 million as it advances toward its 2033 valuation target.

Key Drivers Shaping Market Growth

Several factors are propelling the growth of the GABA Supplements Market:

1. Rising Demand for Sleep Aids and Relaxation Supplements

The prevalence of sleep-related issues and insomnia has created a heightened need for dietary supplements that aid relaxation and promote sleep quality. According to the Sleep Foundation, approximately 30-48% of adults worldwide experience insomnia, with 10-30% suffering from chronic insomnia. The situation is notably pronounced in Japan, where more than 70% of the population reports sleep dissatisfaction, as well as in the United States, United Kingdom, and South Korea, where around 60% of adults face similar challenges. Consequently, GABA supplements, which are known to induce calming effects by supporting neurotransmitter activity, are expected to see an increase in demand.

2. Impact of COVID-19 on Mental Health

The World Health Organization (WHO) has highlighted that the COVID-19 pandemic has led to a global rise in anxiety and depression, with a reported increase of around 25%. This surge has driven demand for products that can help alleviate mental health challenges, including GABA supplements. Their ability to support relaxation and reduce anxiety presents a natural alternative to traditional pharmacological treatments, offering an attractive solution to a growing mental health crisis.

3. Health Benefits for Specific Conditions

GABA supplementation has been linked to several health benefits beyond mental well-being, including the regulation of blood pressure. In 2021, the WHO estimated that 1.3 billion adults aged 30 to 79 suffered from hypertension, with nearly 45% of cases undiagnosed. Research indicates that consuming 80 milligrams of GABA can lead to significant blood pressure reductions, thereby creating a promising niche market for GABA supplements in managing hypertension.

4. Role in Alleviating Hormonal Imbalances

The potential for GABA supplements to reduce symptoms associated with hormonal disorders such as premenstrual dysphoric disorder (PMDD) adds another dimension to their market appeal. An estimated six million women suffer from PMDD, characterized by anxiety, mood swings, and irritability. By promoting relaxation and improving mood, GABA supplements are positioned to gain traction as a natural support for hormonal health.

Regional Insights: Leading Markets and Growth Projections

North America: A Key Growth Hub

North America emerged as a significant market for GABA supplements, with sales reaching USD 17.3 million in 2022 and projected to increase to USD 31.4 million by 2033. The high incidence of sleep disorders in the United States, where over 21% of adults report experiencing insomnia nightly, underscores the potential demand for GABA supplements. Furthermore, chronic stress affects around 36% of Canadians, boosting the regional demand for products that offer stress reduction and relaxation benefits.

United States Market Analysis

In the U.S., the GABA Supplements Market is projected to grow at a CAGR of 4.6% from 2023 to 2033, driven by the high prevalence of anxiety disorders, which affect approximately 40 million adults annually. Despite the availability of treatments, only 37% of individuals seek professional help, suggesting a gap that dietary supplements could fill. GABA supplements offer a non-pharmacological alternative for those looking to manage anxiety symptoms, making the U.S. a key market for expansion.

United Kingdom Market Outlook

In the United Kingdom, the market is expected to achieve a valuation of USD 3.8 million by 2033, with a CAGR of 4.9%. The surge in demand for GABA supplements can be attributed to the rising cases of anxiety and depression, which intensified during the COVID-19 pandemic. The increase in consumption of sleep aids, such as sleeping pills, by 25% in 2020 compared to 2019, signals an opportunity for non-prescription alternatives like GABA supplements.

Japan: Meeting the Need for Sleep Solutions

Japan is another significant market, with an expected growth to USD 5.5 million by 2033. High rates of insomnia, with nearly half of the population affected, and frequent searches for sleep solutions indicate an opportunity for growth. GABA supplements, which are associated with enhancing sleep quality, are expected to gain popularity as a solution for Japan's widespread sleep issues.

China: Addressing Widespread Sleep Disorders

The GABA Supplements Market in China is set to grow at a CAGR of 6.7% from 2023 to 2033, reaching USD 6.5 million. With over 300 million people suffering from sleep disorders in 2018 and persistent issues reported in recent years, there is a significant market opportunity for dietary supplements aimed at improving sleep and relaxation.

South Korea: Embracing Holistic Wellness Trends

South Korea's GABA Supplements Market is projected to grow to USD 3 million by 2033, driven by an increasing awareness of mental health and stress management. With nearly 95% of Koreans reporting stress-related concerns and one-third experiencing chronic stress, the demand for natural supplements that promote relaxation is expected to rise. The integration of beauty and wellness trends, such as the use of GABA for improving sleep and skin health, further supports market expansion in South Korea.

Competitive Landscape:

Leading Companies and Strategies
Key players in the GABA Supplements Market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer various forms of GABA supplements, such as capsules, lozenges, powders. The focus on consumer education is evident through initiatives like stress-measuring tests, FAQs, and informative content on their websites, which guide users in selecting the appropriate supplements.

In August 2022, Amorepacific, a South Korean beauty brand, introduced Good Sleep GABA 365, a supplement designed to enhance sleep efficiency. This launch reflects the growing trend of integrating mental wellness with beauty, particularly in markets where sleep and skincare are closely related to overall well-being.

Market Segmentation: Product Forms and Distribution Channels

Product Forms
• Capsules: The most popular form of GABA supplements, with a projected CAGR of 5% from 2023 to 2033.
• Lozenges, Powders: Offering alternative consumption methods for users who prefer not to take capsules.

Distribution Channels
• Online Stores: E-commerce remains a significant channel due to its convenience and the availability of customer reviews.
• Pharmacies and Supermarkets: Traditional brick-and-mortar stores still play a vital role, especially for customers who prefer purchasing health products in person.

Emerging Trends and Opportunities

1. Increased Adoption for Hypertension Management
As studies continue to validate the role of GABA supplements in managing blood pressure, there is potential for these products to be integrated into heart health regimens, expanding their target audience beyond stress and sleep-related applications.

2. Combining Mental Wellness with Beauty

The convergence of the beauty and wellness industries, particularly in regions like South Korea, presents opportunities for GABA supplements positioned as dual-purpose products that support relaxation and skin health.

3. Growth in E-commerce Sales

The rising popularity of online health and wellness stores provides brands with the opportunity to reach a broader audience, particularly in regions where access to physical stores may be limited.

Read More: https://www.persistencemarketresearch.com/market-research/gaba-supplements-market.asp

Conclusion

The GABA Supplements Market is poised for sustained growth, driven by increasing consumer awareness of the benefits of natural supplements for managing stress, sleep disorders, and hypertension. With robust demand across North America, Asia-Pacific, and Europe, the market will continue to evolve, catering to diverse health needs and preferences. Companies that can innovate and educate consumers on the benefits of GABA supplements are well-positioned to capitalize on this growing market, ensuring continued expansion throughout the forecast period.

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.